查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区显影剂与注射器系统市场：分析与预测（2022-2026）
市场调查报告书
商品编码
1415581

亚太地区显影剂与注射器系统市场：分析与预测（2022-2026）

Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026
出版日期: | 出版商: BIS Research | 英文 88 Pages | 商品交期: 1-5个工作天内

价格

根据预测，亚太地区显影剂和注射系统市场规模预计将从2022年的19.8亿美元成长到2026年的26.2亿美元，预测期内复合年增长率为7.24%。

该市场受到癌症和心血管疾病发病率增加等因素的推动，导致对显影剂、注射系统和影像引导诊断的需求增加。

主要市场统计数据
预测期 2022-2026
2022年评估 19.8亿美元
2026年预测 26.2亿美元
复合年增长率 7.24%

由于几个关键因素，亚太地区显影剂和注射系统市场正在显着成长。首先，癌症和心血管疾病等疾病发生率的上升增加了对显影剂和注射系统的诊断影像的需求。这对于准确的诊断和治疗计划尤其重要。

其次，医学影像处理技术的进步进一步推动市场成长。创新显影剂和注射系统的开发提高了诊断程序的准确性和有效性，使医疗保健提供者更容易获得和可靠。

最后，亚太地区医疗基础设施的扩张和医疗支出的增加也促进了市场的扩张。随着医疗机构不断现代化和升级其成像能力，该地区对影像处理显影剂和注射系统的需求预计将继续呈上升趋势。

本报告调查了亚太地区显影剂和注射系统市场，并提供了市场概况、市场成长的各种影响因素分析、法律制度、专利趋势、市场规模趋势和预测以及主要国家的细分我们对主要企业进行了详细的分析和总结。

市场分类

细分 1：依产品分类

  • 显影剂
  • 注射系统

细分：喷射器系统：副产品

  • 注射器
  • 耗材及配件

细分 2：按国家/地区

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 其他的

目录

执行摘要

调查范围

调查方法

第一章 市场

  • 市场展望
  • 市场概况
  • 产业展望
    • 监管和法律要求及框架
    • 专利分析
    • 主要趋势
  • COVID-19 对显影剂和注射器系统市场的影响
  • 市场动态
    • 影响分析
    • 市场驱动因素
    • 市场抑制因素
    • 市场机会

第二章 区域

  • 概述
  • 亚太地区
    • 主要发现
    • 市场动态
    • 市场规模/预测

第三章市场：竞争基准化分析与公司概况

  • 竞争基准化分析
    • 主要策略和发展
    • 市场占有率分析
  • 显影剂生态系中的活跃公司
  • 公司简介
    • Beijing Beilu Pharmaceutical Co. Ltd.
    • FUJIFILM Holdings Corporation
    • Jiangsu Hengrui Pharmaceutical Co., Ltd.
    • Jodas Expoim Pvt. Ltd.
    • Shenzen Seacrown Electromechanical Co., Ltd.
    • Sino Medical-Device Technology Co., Ltd.
    • Unijules Life Sciences Ltd.
Product Code: BHR1815SS

“The Asia-Pacific Contrast Media Agent and Injector System Market Expected to Reach $2.62 Billion by 2026.”

Introduction to Asia-Pacific Contrast Media Agent and Injector System Market

The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

KEY MARKET STATISTICS
Forecast Period2022 - 2026
2022 Evaluation$1.98 Billion
2026 Forecast$2.62 Billion
CAGR7.24%

Market Introduction

The APAC Contrast Media Agent and Injector System Market is witnessing substantial growth driven by several key factors. Firstly, the rising incidence of medical conditions such as cancer and cardiovascular diseases has led to an increased demand for imaging procedures that require contrast media agents and injector systems. This is particularly crucial for accurate diagnosis and treatment planning.

Secondly, advancements in medical imaging technologies have further fueled market growth. The development of innovative contrast media agents and injector systems has improved the precision and effectiveness of diagnostic procedures, making them more accessible and reliable for healthcare providers.

Lastly, the expanding healthcare infrastructure and increasing healthcare expenditure in the Asia-Pacific region have contributed to the market's expansion. As healthcare facilities continue to modernize and upgrade their imaging capabilities, the demand for contrast media agents and injector systems is expected to continue its upward trajectory in the region.

Market Segmentation:

Segmentation 1: by Product

  • Contrast Media Agents
  • Injector Systems

Segmentation: Injector Systems (by Product)

  • Injector
  • Consumables and Accessories

Segmentation 2: by Country

  • China
  • Japan
  • India
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The APAC contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled

  • Beijing Beilu Pharmaceutical Co. Ltd.
  • FUJIFILM Holdings Corporation
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Shenzen Seacrown Electromechanical Co., Ltd.
  • Sino Medical-Device Technology Co., Ltd.
  • Unijules Life Sciences Ltd.

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Markets

  • 1.1. Market Outlook
    • 1.1.1. Product Definition
    • 1.1.2. Inclusion and Exclusion Criteria
  • 1.2. Market Overview
  • 1.3. Industry Outlook
    • 1.3.1. Regulatory and Legal Requirements and Framework
      • 1.3.1.1. Regulatory and Legal Requirements and Framework in Asia-Pacific
        • 1.3.1.1.1. China
        • 1.3.1.1.2. Japan
    • 1.3.2. Patent Analysis
      • 1.3.2.1. Patent Filing Trend (by Year)
      • 1.3.2.2. Patent Filing Trend (by Country)
    • 1.3.3. Key Trends
      • 1.3.3.1. Nanoparticle-Based Contrast Agents
      • 1.3.3.2. Development of Safer Contrast Media Agent
      • 1.3.3.3. Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
  • 1.4. Impact of COVID-19 on Contrast Media Agent and Injector System Market
    • 1.4.1. Pre-COVID-19 Impact
    • 1.4.2. During COVID-19 Impact
    • 1.4.3. Post-COVID-19 Impact
  • 1.5. Market Dynamics
    • 1.5.1. Impact Analysis
    • 1.5.2. Market Drivers
      • 1.5.2.1. Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
      • 1.5.2.2. Upsurge in Demand for Image-Guided Diagnostics
      • 1.5.2.3. Growing Number of Regulatory Approvals
    • 1.5.3. Market Restraints
      • 1.5.3.1. Rising Health Concerns Post Usage of Contrast Media Agents in Body
    • 1.5.4. Market Opportunities
      • 1.5.4.1. IT Advances in Contrast Media Injectors

2. Region

  • 2.1. Overview
  • 2.2. Asia-Pacific
    • 2.2.1. Key Findings
    • 2.2.2. Market Dynamics
      • 2.2.2.1. Impact Analysis
    • 2.2.3. Market Size and Forecast
      • 2.2.3.1. Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.1.1. Asia-Pacific Contrast Media Injector System Market (by Product)
      • 2.2.3.2. Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
        • 2.2.3.2.1. China
          • 2.2.3.2.1.1. Market Sizing and Forecast
          • 2.2.3.2.1.1.1. China Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.1.1.1.1. China Contrast Media Injector System Market (by Product)
        • 2.2.3.2.2. Japan
          • 2.2.3.2.2.1. Market Sizing and Forecast
          • 2.2.3.2.2.1.1. Japan Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.2.1.1.1. Japan Contrast Media Injector System Market (by Product)
        • 2.2.3.2.3. India
          • 2.2.3.2.3.1. Market Sizing and Forecast
          • 2.2.3.2.3.1.1. India Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.3.1.1.1. India Contrast Media Injector System Market (by Product)
        • 2.2.3.2.4. Australia
          • 2.2.3.2.4.1. Market Sizing and Forecast
          • 2.2.3.2.4.1.1. Australia Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.4.1.1.1. Australia Contrast Media Injector System Market (by Product)
        • 2.2.3.2.5. Rest-of-Asia-Pacific
          • 2.2.3.2.5.1. Market Sizing and Forecast
          • 2.2.3.2.5.1.1. Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.5.1.1.1. Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)

3. Markets - Competitive Benchmarking & Company Profiles

  • 3.1. Competitive Benchmarking
    • 3.1.1. Key Strategies and Development
      • 3.1.1.1. Regulatory and Legal Activities
      • 3.1.1.2. Partnerships, Collaborations, and Business Expansions
      • 3.1.1.3. Mergers and Acquisitions
      • 3.1.1.4. New Offerings
    • 3.1.2. Market Share Analysis
      • 3.1.2.1. Market Share Analysis, by Contrast Media Agent Market
      • 3.1.2.2. Market Share Analysis, by Contrast Media Injector System Market
  • 3.2. Contrast Media Ecosystem Active Players
  • 3.3. Company Profiles
    • 3.3.1. Beijing Beilu Pharmaceutical Co. Ltd.
      • 3.3.1.1. Company Overview
      • 3.3.1.2. Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.1.3. Recent Developments
      • 3.3.1.4. Analyst Perception
    • 3.3.2. FUJIFILM Holdings Corporation
      • 3.3.2.1. Company Overview
      • 3.3.2.2. Role of FUJIFILM Holdings Corporation in the Contrast Media Agent and Injector System Market
      • 3.3.2.3. Financials
      • 3.3.2.4. Analyst Perception
    • 3.3.3. Jiangsu Hengrui Pharmaceutical Co., Ltd.
      • 3.3.3.1. Company Overview
      • 3.3.3.2. Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.3.3. Recent Developments
      • 3.3.3.4. Analyst Perception
    • 3.3.4. Jodas Expoim Pvt. Ltd.
      • 3.3.4.1. Company Overview
      • 3.3.4.2. Role of Jodas Expoim Pvt. Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.4.3. Analyst Perception
    • 3.3.5. Shenzen Seacrown Electromechanical Co., Ltd.
      • 3.3.5.1. Company Overview
      • 3.3.5.2. Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.5.3. Recent Developments
      • 3.3.5.4. Analyst Perception
    • 3.3.6. Sino Medical-Device Technology Co., Ltd.
      • 3.3.6.1. Company Overview
      • 3.3.6.2. Role of Sino Medical-Device Technology Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.6.3. Analyst Perception
    • 3.3.7. Unijules Life Sciences Ltd.
      • 3.3.7.1. Company Overview
      • 3.3.7.2. Role of Unijules Life Sciences Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.7.3. Analyst Perception

List of Figures

  • Figure 1: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 3: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
  • Figure 4: Contrast Media Agent and Injector System Market (by Region), $Million, 2021 and 2026
  • Figure 5: Contrast Media Agent and Injector System Market: Research Methodology
  • Figure 6: Primary Research Methodology
  • Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 8: Top-Down Approach (Segment-Wise Analysis)
  • Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
  • Figure 10: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
  • Figure 11: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
  • Figure 12: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 13: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
  • Figure 14: Incidence of Cardiovascular Disease, 2015 - 2019, Million
  • Figure 15: Innovative Vendors Product Solutions
  • Figure 16: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
  • Figure 17: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 18: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 19: Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 20: Asia-Pacific Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 21: China Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 22: China Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 23: China Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 24: Japan Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 25: Japan Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 26: Japan Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 27: India Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 28: India Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 29: India Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 30: Australia Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 31: Australia Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 32: Australia Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 33: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 34: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 35: Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 36: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
  • Figure 37: Regulatory and Legal Activities, January 2018-May 2023
  • Figure 38: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
  • Figure 39: Mergers and Acquisitions, January 2018-May 2023
  • Figure 40: New Offerings, January 2018-May 2023
  • Figure 41: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 42: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 43: Beijing Beilu Pharmaceutical Co. Ltd.: Product Portfolio
  • Figure 44: FUJIFILM Holdings Corporation: Overall Product Portfolio
  • Figure 45: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2020-2022
  • Figure 46: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 47: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2020-2022
  • Figure 48: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 49: Jiangsu Hengrui Pharmaceutical Co., Ltd.: Product Portfolio
  • Figure 50: Jodas Expoim Pvt. Ltd.: Product Portfolio
  • Figure 51: Shenzen Seacrown Electromechanical Co., Ltd.: Product Portfolio
  • Figure 52: Sino Medical-Device Technology Co., Ltd.: Product Portfolio
  • Figure 53: Unijules Life Sciences Ltd.: Product Portfolio

List of Tables

  • Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
  • Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
  • Table 5: Some of the Contrast Media Reactions and Effects
  • Table 6: Guidelines for Contrast Administration and Hydration
  • Table 7: Asia-Pacific Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 8: Contrast Media Ecosystem Active Players